Anti-Human CDw60 – PerCP

Pricing & Details

Product No.C1905
Clone
Jones
Protein
CDw60
Formats AvailableView All
Product Type
Monoclonal Antibody
Alternate Names
9-0-acetyl GD3
Isotype
Mouse
IgM
Applications
FC
Prod No.
Size
Price
Avail.
Qty
Add to cart
C1905-Custom
Custom
In stock
Bulk quantities available. Contact us for pricing.

Antibody Details

Product Details

Reactivity Species
Human
Host Species
Mouse
Immunogen
Purified Recombinant Human CDw60 (>98%)
Product Concentration
0.1 mg/ml
Formulation
This PerCP conjugate is formulated in 0.01 M phosphate buffered saline (PBS) pH 7.4, 150 mM NaCl, 1% BSA and 0.09% sodium azide as a preservative.
Storage and Handling
This PerCP conjugate is stable when stored at 2-8°C. Do not freeze.
Country of Origin
USA
Shipping
Next Day 2-8°C
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Specificity
Mouse Anti-Human CDw60 (Clone Jones) recognizes an epitope on Human CDw60. This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Antigen Distribution
The CDw60 antigen is present on gangliosides, platelets and a subset of CD4+, CD8+ peripheral T-cells, but not on B-cells, monocytes or granulocytes. CDw60 is involved in the co-stimulation of T-cells. The antigen is also detectable in some previously undescribed benign and malignant tumors. CDw60 shows different subcellular distribution patterns.

Antigen Details

Protein
PubMed

References & Citations

1. Leukocyte Typing V (1995) Oxford University Press 2. Blum, A. S. and Barnstable, C. J. et al. (1987) Proc. Natl. Acad. Sci. 84:8716 3. Constantine-Paton, M. et al. (1986) Nature 324:659
Flow Cytometry

Formats Available

Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Leinco Technologies uses cookies to improve your experience and our website service. By continuing to browse our website, you accept our cookie policy. Ok